Clinical Trials
Study Title:
Phase II Trial of Sparing the Urethra, Pudendal Artery and Rectum During Stereotactic Ablative Body Radiotherapy (SUPR-SABR) for Favorable and Intermediate Risk Prostate Cancer
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Harriet Eldredge-Hindy, at eldredge@musc.edu.
Study Coordinator, Zachary Bargeloh, at bargeloh@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |